The tested sample of Zoledronic Acid Noridem 4 mg/5 ml, concentrate for solution for infusion, failed appearance requirements due to the presence of particles visible to the naked eye in the solution. Potencjalne skutki: thromboembolic complications, vascular damage, lack of safety of intravenous therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ